Hot growth stock ( FIT )
By Jeff Reeves
Fitbit is a fast-growing stock that is a dominant name in the rapidly expanding realm of fitness wearables. Fitbit has powerful momentum — and most importantly, solid profits. The deck seems stacked for blowout earnings surprises as Fitbit continues to maintain its strong brandin the wearables space. Fitbit remains the gold standard with its huge brand recogntion, the tailwind of organic growth in wearables, and robust profit margins
The Fly On The Wall
Synergy Pharmaceuticals price target raised to $19 from $11 at Canaccord. Canaccord raised its price target on Synergy Pharmaceuticals to $19 from $11 following positive top-line results from its Phase 3 trial for plecanatide in chronic idiopathic constipation.
Research Firm IDC says “ Fitbit year-over year growth rate has been astounding”. Their customer service is considered excellent” Their products are getting rave reviews and it’s selling itself via referrals
$70's coming soon.
good link right on The Fly
Sentiment: Strong Buy
buyers will wait till July too risky with IRWD already approved.
Jim Cramer's Top Takeaways: Box, Netflix, Fitbit, Chipotle, Facebook
( FIT )
investors know when the smoke has cleared and it's safe to buy? Cramer said they should look to the high-growth stocks like these three stalwarts, you just can't keep a good growth stock down for long, Cramer noted, and that's why he always circles back to the cult stocks after any market pullbacks.
From Last Earnings Transcript:
Netflix (NFLX) Earnings Report: Q2 2015 Conference Call Transcript
The Street TranscriptsFollow 07/16/15 - 07:53 AM Reed Hastings CEO "There is a series of these international launches we have aggressively planned for this year and next year Less
he has been right on with NFLX reached all his targets
bought- make money